| Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy S Costantino, A Akhmedov, G Melina, SA Mohammed, A Othman, ... European heart journal 40 (12), 997-1008, 2019 | 81 | 2019 |
| Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity S Costantino, F Paneni, A Virdis, S Hussain, SA Mohammed, G Capretti, ... European Heart Journal 40 (4), 383-391, 2019 | 58 | 2019 |
| Inflammation in metabolic cardiomyopathy FA Wenzl, S Ambrosini, SA Mohammed, S Kraler, TF Lüscher, ... Frontiers in cardiovascular medicine 8, 742178, 2021 | 57 | 2021 |
| Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc S Costantino, F Paneni, K Mitchell, SA Mohammed, S Hussain, C Gkolfos, ... International journal of cardiology 268, 179-186, 2018 | 53 | 2018 |
| Epigenetic processing in cardiometabolic disease S Costantino, SA Mohammed, S Ambrosini, F Paneni Atherosclerosis 281, 150-158, 2019 | 52 | 2019 |
| Epigenetic control of mitochondrial function in the vasculature SA Mohammed, S Ambrosini, T Lüscher, F Paneni, S Costantino Frontiers in cardiovascular medicine 7, 28, 2020 | 41 | 2020 |
| Epigenetics and cardiovascular regenerative medicine in the elderly S Costantino, GG Camici, SA Mohammed, M Volpe, TF Lüscher, F Paneni International journal of cardiology 250, 207-214, 2018 | 41 | 2018 |
| Hyperglycemia induces myocardial dysfunction via epigenetic regulation of JunD S Hussain, AW Khan, A Akhmedov, R Suades, S Costantino, F Paneni, ... Circulation research 127 (10), 1261-1273, 2020 | 39 | 2020 |
| The BET protein inhibitor apabetalone rescues diabetes-induced impairment of angiogenic response by epigenetic regulation of thrombospondin-1 SA Mohammed, M Albiero, S Ambrosini, E Gorica, G Karsai, ... Antioxidants & Redox Signaling 36 (10), 667-684, 2022 | 24 | 2022 |
| Deletion of fibroblast activation protein provides atheroprotection S Stein, J Weber, S Nusser-Stein, J Pahla, HE Zhang, SA Mohammed, ... Cardiovascular research 117 (4), 1060-1069, 2021 | 24 | 2021 |
| Epigenetic remodeling in obesity-related vascular disease S Masi, S Ambrosini, SA Mohammed, S Sciarretta, TF Luescher, F Paneni, ... Antioxidants & redox signaling 34 (15), 1165-1199, 2021 | 23 | 2021 |
| Epi-drugs in heart failure E Gorica, SA Mohammed, S Ambrosini, V Calderone, S Costantino, ... Frontiers in cardiovascular medicine 9, 923014, 2022 | 20 | 2022 |
| New mechanisms of vascular dysfunction in cardiometabolic patients: focus on epigenetics S Ambrosini, SA Mohammed, TF Lüscher, S Costantino, F Paneni High Blood Pressure & Cardiovascular Prevention 27, 363-371, 2020 | 15 | 2020 |
| Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study S Ambrosini, F Montecucco, D Kolijn, D Pedicino, A Akhmedov, ... Cardiovascular research 118 (17), 3374-3385, 2022 | 13 | 2022 |
| Epigenetic remodeling in heart failure with preserved ejection fraction S Ambrosini, E Gorica, SA Mohammed, S Costantino, F Ruschitzka, ... Current Opinion in Cardiology 37 (3), 219-226, 2022 | 8 | 2022 |
| Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine. S Ambrosini, SA Mohammed, S Costantino, F Paneni Minerva Cardiology and Angiology 69 (3), 331-345, 2020 | 8 | 2020 |
| The vascular epigenome in patients with obesity and type 2 diabetes: opportunities for personalized therapies S Costantino, SA Mohammed, S Ambrosini, F Paneni Vascular Biology 2 (1), H19-H28, 2020 | 8 | 2020 |
| Circulating long noncoding RNA signatures associate with incident diabetes in older adults: a prospective analysis from the VITA cohort study FA Wenzl, A Mengozzi, SA Mohammed, NR Pugliese, A Mongelli, ... Diabetes Care 46 (6), 1239-1244, 2023 | 5 | 2023 |
| Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy S Costantino, A Mengozzi, S Velagapudi, SA Mohammed, E Gorica, ... Cardiovascular Diabetology 22 (1), 312, 2023 | 4 | 2023 |
| Mitochondrial epigenetics in aging and cardiovascular diseases A Mongelli, A Mengozzi, M Geiger, E Gorica, SA Mohammed, F Paneni, ... Frontiers in cardiovascular medicine 10, 2023 | 4 | 2023 |
Francesco Paneni,Professor of Cardiology and Director of CTEC, University of Zurich and Zurich University Hospital,Verified email at uzh.ch
